297 related articles for article (PubMed ID: 25990619)
1. Update on hepatitis C: epidemiology, treatment and resistance to antiviral therapies.
Ness E; Kowdley KV
Minerva Gastroenterol Dietol; 2015 Sep; 61(3):145-58. PubMed ID: 25990619
[TBL] [Abstract][Full Text] [Related]
2. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
Jacobson IM; Lim JK; Fried MW
Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
[TBL] [Abstract][Full Text] [Related]
3. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
Michielsen P; Ho E; Francque S
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
[TBL] [Abstract][Full Text] [Related]
4. From current status to optimization of HCV treatment: Recommendations from an expert panel.
Craxì A; Perno CF; Viganò M; Ceccherini-Silberstein F; Petta S;
Dig Liver Dis; 2016 Sep; 48(9):995-1005. PubMed ID: 27388261
[TBL] [Abstract][Full Text] [Related]
5. Predicted effects of treatment for HCV infection vary among European countries.
Deuffic-Burban S; Deltenre P; Buti M; Stroffolini T; Parkes J; Mühlberger N; Siebert U; Moreno C; Hatzakis A; Rosenberg W; Zeuzem S; Mathurin P
Gastroenterology; 2012 Oct; 143(4):974-85.e14. PubMed ID: 22863764
[TBL] [Abstract][Full Text] [Related]
6. Antiviral treatment for cirrhosis due to hepatitis C: a review.
Somasundaram A; Venkataraman J
Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
[TBL] [Abstract][Full Text] [Related]
7. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
[TBL] [Abstract][Full Text] [Related]
8. Estimates on HCV disease burden worldwide - filling the gaps.
Wedemeyer H; Dore GJ; Ward JW
J Viral Hepat; 2015 Jan; 22 Suppl 1():1-5. PubMed ID: 25560838
[TBL] [Abstract][Full Text] [Related]
9. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
10. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of interferon-based therapy for chronic hepatitis C.
Yu ML; Huang CF; Dai CY; Huang JF; Chuang WL
Oncology; 2007; 72 Suppl 1():16-23. PubMed ID: 18087178
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
Ueno Y; Sollano JD; Farrell GC
J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing and treating hepatitis C virus infection.
Schiff ER
Am J Manag Care; 2011 Mar; 17 Suppl 4():S108-15. PubMed ID: 21767067
[TBL] [Abstract][Full Text] [Related]
14. Antiviral therapy: why does it fail in HCV-related chronic hepatitis?
Masarone M; Persico M
Expert Rev Anti Infect Ther; 2011 May; 9(5):535-43. PubMed ID: 21609265
[TBL] [Abstract][Full Text] [Related]
15. Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model.
Petta S; Di Marco V; Bruno S; Enea M; Calvaruso V; Boccaccio V; Rossi S; Craxì A; Cammà C
Liver Int; 2016 Dec; 36(12):1765-1773. PubMed ID: 27164508
[TBL] [Abstract][Full Text] [Related]
16. Follow-up of patients with chronic hepatitis C and a sustained viral response.
Serfaty L
Liver Int; 2016 Jan; 36 Suppl 1():67-71. PubMed ID: 26725900
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis C in southern Taiwan.
Chuang WL; Yu ML; Dai CY; Chang WY
Intervirology; 2006; 49(1-2):99-106. PubMed ID: 16166797
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C].
Moradpour D; Blum HE
Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
[TBL] [Abstract][Full Text] [Related]
19. [Chronic hepatitis C].
Grammatikos G; Sarrazin C
Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
[TBL] [Abstract][Full Text] [Related]
20. Natural history of hepatitis C and the impact of anti-viral therapy.
Boyer N; Marcellin P
Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
